| Authors: |
Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Adam V; Breast International Group, Brussels, Belgium., O'Reilly S; Cancer Trials Ireland, Dublin, Ireland., Van Cauwenberge J; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium., Arahmani A; Breast International Group, Brussels, Belgium., Arteaga CL; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas., Bedard PL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada.; University Health Network, Department of Medicine, University of Toronto, Toronto, Canada., Bliss J; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom., Boussis P; Breast International Group, Brussels, Belgium., Brain E; Department of Medical Oncology, Institut Hospitalo-Universitaire des Cancers des Femmes (ANR-23-IAHU-0006), Institut Curie, Saint-Cloud, France., Buyse M; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium.; I-Biostat, Hasselt University, Hasselt, Belgium., Caballero C; Breast International Group, Brussels, Belgium., Cameron D; University of Edinburgh and NHS Lothian, Edinburgh, United Kingdom., Cardoso F; Advanced Breast Cancer (ABC) Global Alliance, Lisbon, Portugal., Carrasco E; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Breast International Group, Brussels, Belgium., Casas A; Breast International Group, Brussels, Belgium.; Fundacion Actitud frente al Cáncer (AFAC), Sevilla, Spain.; Department of Medical Oncology, University Hospital Virgen del Rocío, Sevilla, Spain.; SOLTI Cáncer Research Group, Barcelona, Spain., Chua B; Faculty of Medicine and Health, University of New South Wales, Sydney, Australia., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy.; European Institute of Oncology, IRCCS, Milano, Italy., DeMichele A; Abramson Cancer Center, University of Pennsylvania, Philadelphia., Esserman L; Department of Surgery, University of California, San Francisco., Floris G; Department of Pathology, University Hospitals Leuven, Leuven, Belgium.; Laboratory for Translational Cell and Tissue Research, Department of Imaging and Pathology, KU-Leuven, Leuven, Belgium., Goetz MP; Department of Oncology, Mayo Clinic, Rochester, Minnesota., Goulioti T; Breast International Group, Brussels, Belgium., Haibe-Kains B; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Medical Biophysics, University of Toronto, Toronto, Canada.; Structural Genomics Consortium, Toronto, Canada.; Vector Institute for Artificial Intelligence, Toronto, Canada., Hodgdon C; Guiding Researchers and Advocates to Scientific Partnerships (GRASP), Baltimore, Maryland., Ignatiadis M; Breast Medical Oncology Clinic and Program, Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Kok M; Departments of Medical Oncology and Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lacombe D; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Linderholm B; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.; Department of Oncology, Sahlgrenska University Hospital, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden., Loi S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Parkville, Australia., Lord CJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., MacKenzie M; Independent Cancer Patients' Voice (ICPV), London, United Kingdom., Maues J; Guiding Researchers and Advocates to Scientific Partnerships (GRASP), Washington, DC., Meheus L; Anticancer Fund, Meise, Belgium., Needham J; Canadian Cancer Trials Group, Kingston, Canada., Neven P; Department of Gynecological Oncology, University Hospitals Leuven, Leuven, Belgium., Parsons H; Breast Oncology Program, Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Piccart M; Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium., Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Razis E; 3rd Medical Oncology Department, Hygeia Hospital, Athens, Greece., Saji S; Department of Medical Oncology, Fukushima Medical University, Fukushima Japan., Schumacher-Wulf E; Mamma Mia! Breast Cancer Magazine, Köln, Germany., Sonke GS; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; University of Amsterdam, Amsterdam, the Netherlands., Spanic T; Europa Donna Slovenia, Ljubljana, Slovenia.; Europa Donna-European Breast Cancer Coalition, Milan, Italy., Tannock IF; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; University of Toronto, Toronto, Canada., Tutt A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; The Breast Cancer Now Research Unit, Guy's Hospital Cancer Centre, King's College London, London, United Kingdom., Urruticoechea A; GEICAM Spanish Breast Cancer Group, Madrid, Spain.; Gipuzkoa Cancer Unit, Osakidetza BioGipuzkoa, San Sebastian, Spain., van 't Veer L; University of California, San Francisco., Vaz-Luis I; Cancer Survivorship Group, Inserm Unit 981, Gustave Roussy, Villejuif, France.; Interdisciplinary Patient Pathway Department, Gustave Roussy, Villejuif, France.; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France., Werutsky G; Latin American Cooperative Oncology Group, Porto Alegre, Brazil., Yee D; Masonic Cancer Center, University of Minnesota, Minneapolis., Zaman K; Department of Medical Oncology, Lausanne University Hospital CHUV, Lausanne, Switzerland., Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium. |
